EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 307 filers reported holding EXELIXIS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,434,000 | -38.2% | 144,300 | -42.5% | 0.04% | -7.9% |
| Q1 2018 | $5,560,000 | +796.8% | 251,000 | +1130.6% | 0.04% | +660.0% |
| Q4 2017 | $620,000 | -64.3% | 20,397 | -71.1% | 0.01% | -54.5% |
| Q2 2017 | $1,737,000 | -1.0% | 70,537 | -40.1% | 0.01% | -35.3% |
| Q4 2016 | $1,755,000 | +71.4% | 117,700 | +46.9% | 0.02% | +88.9% |
| Q3 2016 | $1,024,000 | – | 80,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |